Withanolides.
The active compounds in ashwagandha responsible for its stress-reducing and anti-inflammatory effects. Modulates your stress response by regulating cortisol, reduces inflammation, and supports GABA activity in the brain. The result: less anxiety, better sleep, improved physical recovery.
Reviewed March 2026
- Category
- Compound
- Also filed under
- Drive ashwagandha's cortisol reduction (15 25%)Anti inflammatory (NF kB inhibition)Adaptogenic stress response modulation
What Withanolides is, and what it does.
- Does it work
- Suits people who want the standardised part of ashwagandha rather than plain root powder. The withanolide percentage on the label tells you what you are getting.
- How much to take
- Start with 10 to 50mg of withanolides a day, with a meal containing fat. They are steroidal lactones and dissolve poorly in water on their own.
- Time to feel it
- Some people notice a calmer edge within the first few days. The measured changes in stress-hormone rhythm build across two to four weeks.
- The first dose
- Some people notice a calming effect on day 1, especially with higher withanolide concentrations. Most of the benefits build over 2-4 weeks.
- With regular use
- Weeks 2-4: cortisol reduction becomes measurable. Anxiety decreases noticeably. Sleep quality improves. Athletes see better recovery and modest strength gains by week 8.
- How well tolerated
- Well tolerated by most adults. Rare liver reactions have been reported. Anyone taking thyroid medicine, pregnant or breastfeeding should check with their doctor first.
- How it feels
- A gradual unwinding. Stress still lands, but your reaction to it softens and sleep tends to come more easily. Steady rather than dramatic.
- The overlooked benefit
- Two extracts at the same stated percentage can differ, because withaferin A concentrates in the leaf and root-only material carries a different mix.
10 to 50mg a day is where Withanolides works.
Source: Chandrasekhar et al., 2012; Singh et al., 2011
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Reduces cortisol levels
- Reduces anxiety symptoms
- Improves strength and recovery
Questions people ask about Withanolides.
- What's the difference between withanolides and ashwagandha?
- Ashwagandha is the plant. Withanolides are the active compounds inside it. It's like the difference between coffee (the drink) and caffeine (the active compound). When you take ashwagandha, you're really after the withanolides.
- Is higher withanolide percentage always better?
- Not necessarily. KSM-66 (5%) and Sensoril (10%) are both effective but feel different. KSM-66 is more energizing, Sensoril is more calming. Shoden (35%) is ultra-concentrated but less studied. Match the percentage to your goal.
- Can withanolides help with sleep?
- Yes. The cortisol-lowering effect improves sleep quality. Sensoril (higher withanolide content) tends to be more calming and is often taken at night. Studies show improved sleep onset and quality.
- Will withanolides show up on a drug test?
- No. Withanolides are not drugs, not steroids (despite being 'steroidal lactones' chemically), and aren't tested for in standard drug panels.
- How do I know my ashwagandha has enough withanolides?
- Look for a standardization claim on the label: '5% withanolides' or '10% withanolides.' Better yet, choose a branded extract (KSM-66, Sensoril, Shoden) with third-party testing.
- Can I take withanolides long-term?
- Most studies ran 8-12 weeks. Some people cycle (8 weeks on, 2-4 off). Long-term continuous use lacks safety data. The cycling approach is prudent, and the break helps you reassess whether it's still helping.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Withanolides are lipophilic steroidal lactones cleared largely by glucuronidation. Piperine slows UGT-mediated conjugation and intestinal efflux, which raises the exposure a given dose delivers.
Withanolides dissolve poorly in water and depend on micelle formation for uptake. Phospholipid carriers disperse them into mixed micelles, which is why phytosome-style withanolide preparations exist.
Phosphatidylserine blunts the cortisol rise to a stressor at the pituitary and adrenal level. Withanolides act on the same axis from the central side, so the two touch different points of one loop.
Withanolide-standardised ashwagandha extracts are commonly taken in the evening for self-rated stress and sleep quality, and magnesium is used in the same slot. Magnesium acts as a cofactor across neuronal energy metabolism and contributes to normal nervous system function. The pairing is a formulation practice with additive calming intent rather than a tested combination, so the combined effect has not been measured directly.
L-theanine crosses into the central nervous system and shifts electroencephalographic alpha activity, a marker of relaxed wakefulness. Withanolide-standardised extracts are studied for self-rated stress and sleep ratings. Both act on subjective relaxation by different routes, which is why they appear together. No trial of the pair is cited here.
Glycine is an inhibitory neurotransmitter at its own receptor and has been used before bed for sleep quality ratings. Withanolides appear in the same night-time formulas. The two act through separate routes and are combined for that reason, not because a combination has been measured.
Melatonin signals biological night through MT1 and MT2 receptors and shortens self-reported time to fall asleep. Withanolide extracts are taken in the same window for sleep quality ratings. Sedation effects can stack, so anyone combining them should regard drowsiness as additive.
Rhodiola and withanolide-bearing ashwagandha are both described in adaptogen reviews as acting on stress-response signalling, including the hypothalamic-pituitary-adrenal axis. Rhodiola is usually taken in the morning and withanolides at either end of the day. The combination is a traditional and commercial pairing. The shared axis is the rationale, not a measured additive effect.
Bacosides and withanolides are both steroidal or triterpenoid saponin-type molecules studied for cognitive ratings and stress scores. Reviews of brain-health botanicals name them together. That co-listing is not evidence that the two act better together, and no combination trial is cited.
Caffeine is an adenosine receptor antagonist and raises arousal and heart rate. Withanolide extracts are used for the opposite end of the arousal scale. Taken together the subjective effect of one can mask the other, which matters most for anyone using withanolides for evening wind-down.
Withanolides are steroidal lactones with limited water solubility, so a lipid vehicle keeps them dispersed and supports uptake through the intestinal lipid pathway. Medium-chain triglycerides are used in softgels for exactly this reason. Formulation work on newer ashwagandha preparations has focused on this bioavailability problem.
Phospholipid complexes are a standard way to carry poorly water-soluble plant lactones across the intestinal barrier. Phosphatidylcholine forms the bilayer material used in those complexes. This is a formulation relationship, so it changes delivery rather than adding a separate biological effect.
Zinc is a cofactor for hundreds of enzymes and contributes to normal cognitive function and normal testosterone concentrations in blood. Withanolide extracts appear in the same category of formulas. The two are combined for coverage of different nodes rather than because a joint effect has been measured.
Vitamin D3 is converted to a steroid hormone that acts through a nuclear receptor, and withanolides are steroidal lactones studied for stress-axis endpoints. Both appear in mood and resilience formulas. There is no combination trial cited here, so the pairing rests on separate mechanisms.
Magnolia bark honokiol and magnolol are studied for relaxation ratings and appear alongside withanolide extracts in night formulas. Both target subjective calm through different chemistry. Sedative effects can add up, which is the practical point rather than a measured synergy.
Valerian is used for time to fall asleep and is often stacked with withanolide extracts. Both can produce drowsiness. The combination should be regarded as additive for sedation, particularly around driving or machinery.
Passionflower flavonoids are used for self-rated tension and sleep onset. Withanolide extracts occupy the same shelf. Effects on drowsiness are additive by nature, and no trial of the pair is cited here.
Talk to a doctor before taking Withanolides if any of these apply to you: Isolated withanolides may be more potent than expected, Withaferin A has cytotoxic properties at high doses. These are flags to check first, not effects Withanolides is known to cause.
Not medical advice. Show the label to your pharmacist.What Withanolides actually does.
Withanolides are C28 steroidal lactones on an ergostane skeleton with a six-membered lactone ring. Withaferin A and withanolide A get quantified most often, and they're what that percentage on a standardised ashwagandha label is measured against.
They're steroidal lactones that barely dissolve in water, so absorption leans on bile forming micelles and improves when they arrive with a lipid or phospholipid carrier.
Root and leaf material of Withania somnifera carry different withanolide mixes, with withaferin A concentrated more in leaf. Two extracts can state the same percentage and still have different withanolide profiles.
Adaptogen research on withanolides centres on signalling through the hypothalamic-pituitary-adrenal axis and on cellular stress-response proteins like heat shock proteins. That's mechanism described from animal studies and lab studies, not measured results in people.
Where Withanolides comes from.
These come from ashwagandha plants. The root, and sometimes the leaf, is dried and extracted, then the extract is tested until it hits a set withanolide percentage. Two products at the same percentage can still contain a different mix.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Cultivated plants, typically lifted after the growing season. Root and leaf carry different withanolide profiles, so the plant part is declared
Dried, milled material is extracted. The solvent system determines which withanolides and co-extracted sugars carry through
Extract is clarified and the solvent stripped under reduced pressure to protect the lactone ring from heat degradation
The concentrate is blended with carrier until it assays to a stated total withanolide percentage
Dried onto a carrier for capsules and tablets, or dispersed in oil or phospholipid for softgels
Getting Withanolides from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Across randomised trials in adults under stress, withanolide-standardised Withania somnifera extracts lowered circulating cortisol compared with placebo.Systematic review. Della Porta et al., 2023 (Nutrients). PMID 38140274 ↗
- Pooling trials, ashwagandha supplementation raised maximal oxygen uptake in healthy adults and athletes by a small amount.Meta-analysis. Pérez-Gómez et al., 2020 (Nutrients). PMID 32316411 ↗
- Reviewing human trials, withanolide-bearing Withania somnifera extracts were associated with modest gains in cognitive test scores and physical function measures.Systematic review. Zhu et al., 2026 (Frontiers in pharmacology). PMID 42199854 ↗
- A single-dose crossover comparison reported higher plasma appearance of withanolides from a 1.5 percent standardised ashwagandha formulation than from the comparator preparation. This is a pharmacokinetic marker, not a functional outcome.Randomised trial. Ramapalaniappan et al., 2025 (Advances in Therapy). PMID 40748423 ↗
- A placebo-controlled trial of low-dose ashwagandha supplementation reported exercise endurance measures over the supplementation period.Randomised trial. Prajapati et al., 2026 (Phytotherapy Research). PMID 41846233 ↗
- Supplementation with a standardised ashwagandha formulation was reported to improve self-rated stress, mood and sleep quality scores. These are questionnaire ratings rather than clinical endpoints.Randomised trial. Mahadevan et al., 2025 (Advances in Therapy). PMID 40875185 ↗
- A review of tolerability reporting for standardised Withania somnifera root preparations, summarising what has and has not been recorded across the published trial set.Narrative review. Coope et al., 2026 (Pharmaceuticals). PMID 42198398 ↗
- A narrative review of ashwagandha in physical performance contexts, mapping the reported strength, recovery and endurance measures and the limits of the trial base.Narrative review. Nobari et al., 2026 (Nutrition and Metabolism). PMID 41715115 ↗
- A mechanism review of selected plant adaptogens describing system-level, molecular and cellular signalling including stress-axis and cellular stress-response pathways.Narrative review. Such et al., 2026 (Nutrients). PMID 41901106 ↗
- A narrative review naming ashwagandha among phytochemical and fungal compounds discussed for neurostimulating and neuroprotective signalling. Mechanistic, not an efficacy finding.Narrative review. Cipriano et al., 2026 (International Journal of Molecular Sciences). PMID 42074246 ↗
- Computational and functional characterisation of longevity-related pathways under heat stress, with plant-derived compounds including withanolide-type molecules modelled against those targets. Non-human and computational, so it cannot support a human effect.Animal study. Shamana et al., 2026 (In Silico Pharmacology). PMID 41852713 ↗
These are the studies our verdict leans on, chosen from the 295 we read for Withanolides. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
